Inhaler use is a critical aspect of respiratory care, yet many patients are unaware of the correct technique, which can lead to medication failure and serious health consequences. Liam Clutterbuck, a market access and engagement lead at Trudell Medical International, highlights a widespread issue: incorrect inhaler use, particularly with pressurized metered dose inhalers (pMDIs). Up to 80% of people don't use pMDIs correctly, which means that around four million people in the UK alone could be at risk of inadequate medication delivery. This is a significant problem, as it can lead to poor disease control, increased exacerbations, and even preventable deaths from asthma. The issue is not limited to pMDIs; dry powder inhalers (DPIs) also require specific techniques to ensure optimal drug delivery. However, certain patient groups, such as young children, the elderly, and those with muscle weakness, may struggle to generate the necessary inspiratory force for DPIs, making pMDIs a more suitable option. The coordination required between actuation and inhalation is a key challenge. A study found that a mere 0.5-second inhalation delay reduced lung delivery to around 1% of the intended dose, emphasizing the importance of proper technique. This is a widespread issue, and it's not just about individual patients. In the UK, approximately four people die from asthma daily, and two-thirds of these tragic outcomes could be prevented with enhanced basic care and improved treatment adherence. Spacers, or valved holding chambers (VHCs), offer a practical solution to mitigate technique and coordination errors for pMDI users. These devices temporarily hold the medication, making it easier for patients to inhale smoothly and breathe tidally, while significantly reducing throat deposition. Despite decades of evidence supporting their use, spacers are still not prescribed consistently across the NHS. One in ten respiratory health professionals reported that spacers are not consistently prescribed, and many patients either don't receive them, aren't properly instructed in their use, or choose not to use them. This gap in prescribing and patient awareness can be attributed to various factors, including a lack of standardized prescribing, variations in training, pressures in primary care, and a lingering misconception that inhalers are intuitive devices requiring minimal instruction. In reality, inhalers demand careful teaching and regular review. Many patients are unaware that they may not be receiving the intended dose of medicine when they take a puff from their pMDI. This highlights the need for public education to normalize spacer use. Patients, especially adults, often feel uncomfortable using spacers in public, which can lead to localized conditions like oral thrush when a large proportion of the drug dose only reaches the throat or mouth without a spacer. An anatomical model study demonstrated that spacers can reduce medication deposition in the throat by up to 90% compared to pMDI alone. Improving inhaler technique is not a glamorous intervention, but it is one of the most cost-effective and impactful steps we can take to improve respiratory outcomes. By supporting patients in using their inhalers correctly, we can enhance disease control, reduce exacerbations, and ultimately, prevent avoidable loss of life. This issue requires a multi-faceted approach, including better prescribing practices, patient education, and a shift in the perception of spacers as essential tools in respiratory care.
